Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study

Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced‐stage ovarian cancer

(2020) Chueh‐Yi Huang et al.   Journal of Cachexia Sarcopenia and Muscle

Modeling Human Cancer-induced Cachexia

(2019) Erin E. Talbert et al.   Cell Reports

Sarcopenia and ovarian cancer survival: a systematic review and meta‐analysis

(2019) Jorne Ubachs et al.   Journal of Cachexia Sarcopenia and Muscle

Metastasis and cachexia: alongside in clinics, but not so in animal models

(2019) Rebeka Tomasin et al.   Journal of Cachexia Sarcopenia and Muscle

Brown adipose tissue and cancer progression

(2019) Katrina Chu et al.   SKELETAL RADIOLOGY

Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle : update 2019

(2019) Stephan Haehling et al.   Journal of Cachexia Sarcopenia and Muscle

Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning

(2018) Jun Han et al.   Lipids in Health and Disease

Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia

(2018) Fabrizio Pin et al.   Journal of Cachexia Sarcopenia and Muscle

Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer

(2018) Joshua K. Kays et al.   Journal of Cachexia Sarcopenia and Muscle

Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof-of-Concept Study

(2017) Daniel Rooks et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

TNF-α and cancer cachexia: Molecular insights and clinical implications

(2017) Hetal J. Patel et al.   LIFE SCIENCES

The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL

(2017) Paul J Emmerson et al.   NATURE MEDICINE

Constitutive Activation of PI3K in Oocyte Induces Ovarian Granulosa Cell Tumors

(2016) So-Youn Kim et al.   CANCER RESEARCH

The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass

(2016) Oren Rom et al.   FREE RADICAL BIOLOGY AND MEDICINE

Activin A induces skeletal muscle catabolism via p38β mitogen-activated protein kinase

(2016) Hui Ding et al.   Journal of Cachexia Sarcopenia and Muscle

Animal models for cancer cachexia

(2016) Riccardo Ballarò et al.   Current Opinion in Supportive and Palliative Care

AMPK: positive and negative regulation, and its role in whole-body energy homeostasis

(2015) D Grahame Hardie   CURRENT OPINION IN CELL BIOLOGY

Cell Autonomous Phosphoinositide 3-Kinase Activation in Oocytes Disrupts Normal Ovarian Function Through Promoting Survival and Overgrowth of Ovarian Follicles

(2015) So-Youn Kim et al.   ENDOCRINOLOGY

Virtual High-Throughput Screening To Identify Novel Activin Antagonists

(2015) Jie Zhu et al.   JOURNAL OF MEDICINAL CHEMISTRY

MAP3K11/GDF15 axis is a critical driver of cancer cachexia

(2015) Lorena Lerner et al.   Journal of Cachexia Sarcopenia and Muscle

Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients

(2015) Lorena Lerner et al.   Journal of Cachexia Sarcopenia and Muscle

Akt-mediated phosphorylation controls the activity of the Y-box protein MSY3 in skeletal muscle

(2015) Luciana De Angelis et al.   Skeletal Muscle

Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia

(2015) Sarah M Judge et al.   BMC CANCER

A Switch from White to Brown Fat Increases Energy Expenditure in Cancer-Associated Cachexia

(2014) Michele Petruzzelli et al.   Cell Metabolism

Myostatin — From the Mighty Mouse to cardiovascular disease and cachexia

(2014) Thomas Bernd Dschietzig   CLINICA CHIMICA ACTA

Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia

(2014) Serkan Kir et al.   NATURE

Elevated expression of activins promotes muscle wasting and cachexia

(2013) Justin L. Chen et al.   FASEB JOURNAL

Adaptive thermogenesis in adipocytes: Is beige the new brown?

(2013) J. Wu et al.   GENES & DEVELOPMENT

An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy

(2013) E. Lach-Trifilieff et al.   MOLECULAR AND CELLULAR BIOLOGY

Brown and beige fat: development, function and therapeutic potential

(2013) Matthew Harms et al.   NATURE MEDICINE

Understanding the mechanisms and treatment options in cancer cachexia

(2012) Kenneth Fearon et al.   Nature Reviews Clinical Oncology

Definition and classification of cancer cachexia: an international consensus

(2011) Kenneth Fearon et al.   LANCET ONCOLOGY

Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance

(2011) Sílvia Busquets et al.   Journal of Cachexia Sarcopenia and Muscle

Reversing Cachexia

(2010) Michael J. Tisdale   CELL

Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival

(2010) Xiaolan Zhou et al.   CELL

Interleukin 6 as a Key Regulator of Muscle Mass during Cachexia

(2010) James A. Carson et al.   EXERCISE AND SPORT SCIENCES REVIEWS